PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 47 filers reported holding PANACEA ACQUISITION CORP II in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,102,911 | +1.7% | 401,459 | 0.0% | 2.12% | +68.9% |
Q4 2022 | $4,034,663 | +2.6% | 401,459 | 0.0% | 1.26% | +44.1% |
Q3 2022 | $3,934,000 | +0.4% | 401,459 | 0.0% | 0.87% | +12.6% |
Q2 2022 | $3,918,000 | +5.1% | 401,459 | +5.0% | 0.78% | +16.4% |
Q1 2022 | $3,729,000 | +0.5% | 382,500 | 0.0% | 0.67% | +20.4% |
Q4 2021 | $3,710,000 | -0.7% | 382,500 | 0.0% | 0.55% | -0.4% |
Q3 2021 | $3,737,000 | -2.5% | 382,500 | 0.0% | 0.56% | +10.6% |
Q2 2021 | $3,831,000 | – | 382,500 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIT CAPITAL PARTNERS PLC | 900,000 | $9,000,000 | 3.04% |
MYDA Advisors LLC | 600,000 | $6,009,000 | 1.50% |
Sage Rock Capital Management LP | 382,500 | $3,831,000 | 0.50% |
683 Capital Management, LLC | 1,400,000 | $14,022,000 | 0.48% |
Bain Capital Life Sciences Investors, LLC | 500,000 | $5,010,000 | 0.33% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 886,642 | $8,866,000 | 0.25% |
Consonance Capital Management LP | 200,000 | $2,002,000 | 0.24% |
Governors Lane LP | 250,000 | $2,504,000 | 0.18% |
Boxer Capital, LLC | 500,000 | $5,010,000 | 0.18% |
Greenlight Capital | 275,000 | $2,754,000 | 0.17% |